BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 33091360)

  • 1. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
    Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B;
    Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
    Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
    JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
    Mangner N; Farah A; Ohlow MA; Möbius-Winkler S; Weilenmann D; Wöhrle J; Linke A; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Scheller B; Jeger RV;
    Circ Cardiovasc Interv; 2022 Feb; 15(2):e011325. PubMed ID: 35000455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial.
    Mahfoud F; Farah A; Ohlow MA; Mangner N; Wöhrle J; Möbius-Winkler S; Weilenmann D; Leibundgut G; Cuculi F; Gilgen N; Kaiser C; Cattaneo M; Scheller B; Jeger RV
    Clin Res Cardiol; 2022 Jul; 111(7):806-815. PubMed ID: 35220449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial.
    Rissanen TT; Uskela S; Eränen J; Mäntylä P; Olli A; Romppanen H; Siljander A; Pietilä M; Minkkinen MJ; Tervo J; Kärkkäinen JM;
    Lancet; 2019 Jul; 394(10194):230-239. PubMed ID: 31204115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2.
    Gilgen N; Farah A; Scheller B; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Jamshidi P; Leibundgut G; Möbius-Winkler S; Zweiker R; Krackhardt F; Butter C; Bruch L; Kaiser C; Hoffmann A; Rickenbacher P; Mueller C; Stephan FP; Coslovsky M; Jeger R;
    Clin Cardiol; 2018 May; 41(5):569-575. PubMed ID: 29527709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial.
    Scheller B; Rissanen TT; Farah A; Ohlow MA; Mangner N; Wöhrle J; Möbius-Winkler S; Weilenmann D; Leibundgut G; Cuculi F; Gilgen N; Coslovsky M; Mahfoud F; Jeger RV;
    Circ Cardiovasc Interv; 2022 Apr; 15(4):e011569. PubMed ID: 35411792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.
    Cortese B; Testa G; Rivero F; Erriquez A; Alfonso F
    JACC Cardiovasc Interv; 2023 May; 16(9):1054-1061. PubMed ID: 37164603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
    Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design.
    Gao C; He X; Liu Y; Liu J; Jiang Z; Zhu B; Qin X; Xia Y; Zhang T; Wang P; Zhang R; Onuma Y; Xia J; Wang D; Serruys P; Tao L
    BMC Cardiovasc Disord; 2024 Jun; 24(1):319. PubMed ID: 38914951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome.
    Ma YL; Tang XF; Yao Y; Xu N; Song Y; Jiang P; Xu JJ; Wang HH; Jiang L; Liu R; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Chin Med J (Engl); 2018 Jun; 131(12):1397-1405. PubMed ID: 29893356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.
    Rubini Gimenez M; Scheller B; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Cattaneo M; Gilgen N; Kaiser C; Jeger RV
    Clin Res Cardiol; 2023 Jul; ():. PubMed ID: 37495797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial.
    Fahrni G; Scheller B; Coslovsky M; Gilgen N; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Zweiker R; Twerenbold R; Kaiser C; Jeger R;
    Clin Res Cardiol; 2020 Sep; 109(9):1114-1124. PubMed ID: 31993736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.